Bard’s Phasix™ Mesh provides you and your patients an option for a strong durable repair without long-term permanent material.

Material Science

Phasix™ Mesh is constructed of monofilament Poly-4-Hydroxybutyrate (P4HB).

  • A resorbable polymore developed by MIT Scientists1
  • P4HB has been clinically used since 2008.

Material Structure and Strength

  • Fully resorbable monofilament knitted mesh
  • Comparable initial strength to traditional polypropylene mesh2
  • Gradually degrades over time with minimal resorption throughout the initial 12-26 weeks.3
  • Supports repair site up to 12–18 months post implant3

Material Value

  • Fully resorbable mesh may be an appealing option for certain soft tissue repairs where early support is needed but where permanent mesh is not desired.
  • Phasix™ Mesh is intended to handle similarly to polypropylene mesh. In preclinical testing, the material is shown to retain higher strength for a longer period of time than some other fully resorbable materials.3
  • For some patients, Phasix™ Mesh may be an economical alternative to biologic grafts and may address long-term permanent mesh-related concerns.

1Martin DP, Williams SF. “Medical Applications of Poly-4-Hydroxybutyrate: A Strong Flexible Absorbable Biomaterial.” Biochemical Engineering Journal. 2003 (16): 97-105.
2Benchtop test data on file at C. R. Bard, Inc. Results may not correlate to performance in humans.
3Preclinical data on file at C. R. Bard, Inc. Results may not correlate to performance in humans.

Ordering Information

    • 1190100
    • 1/cs.
    • 3”x 3" Round (7.6 cm Round)
    • 1190200
    • 1/cs.
    • 4”x 6” Rectangle (10.2 cm x 15.2 cm)
    • 1190300
    • 1/cs.
    • 6”x 8” Rectangle (15.2 cm x 20.3 cm)
    • 1190400
    • 1/cs.
    • 8”x 10” Rectangle (20.3 cm x 25.4 cm)
    • 1190500
    • 1/cs.
    • 10”x 12” Rectangle (25.4 cm x 30.5 cm)


Indications for Use
Phasix™ Mesh is indicated to reinforce soft tissue where weakness exists, such as the repair of hernia or other fascial defects that require the addition of a reinforcing or bridging material to obtain the desired surgical result.
Because Phasix™ Mesh is fully resorbable, it should not be used in repairs where permanent wound or organ support from the mesh is required.
The placement of Phasix™ Mesh in direct contact with bowel or viscera is not recommended. The safety and product use for patients with hypersensitivities to tetracycline hydrochloride or kanamycin sulfate is unknown.

Use of this device in patients with known allergies to these antibiotics should be avoided.The safety and effectiveness of Phasix™ Mesh in pediatric use has not been evaluated or established. If an infection develops, treat the infection aggressively. An unresolved infection may require removal of the device.
Adverse Reactions
Possible complications include infection, seroma, pain, mesh migration, wound dehiscence, hemorrhage, adhesions, hematoma, inflammation, extrusion and recurrence of the hernia or soft tissue defect.
Please consult package insert for more detailed safety information and instructions for use.